Welcome to Reproductive Medicine & Women Healthcare Conferences

Conference Series LLC LTD Destinations

Target Audience for Reproductive Medicine & Women Healthcare Conferences

Obstetricians/ gynaecologists, Physicians working in Reproductive Medicine or training to become subspecialists in Reproductive Medicine, Clinicians, Embryologists and Scientists who wish to update their knowledge of advanced techniques and scientific innovation, the employees of a specific set of employers or patients with a specific Health condition. Reproductive Medicine, Research Scientists, Nurses, Nurse Practitioners, Physician Assistants, Allied Health Professionals and other Clinicians involved in the care of patients with Women Health.

Benefits of Attending CME Conferences

They encourage discussions, they provide networking opportunities, they introduce new ideas and approaches, they offer practical experience, they explain new or modified regulations, Participation and engagement possibilities, Develop a continuous improvement mentality, Expand Your Resources, Stay Current With Trends by Learning From Powerful Speakers 

Benefits of Attending CPD/CE Conferences

continuing professional development (CPD) is a lifelong learning approach to maintain and enhance professional competencies.

CPD is a concept which has evolved from the need to find a better platform for professionals to face the challenge of keeping themselves up-to-date with new knowledge, discoveries and skills in order to perform better in their professions. CPD can be considered as a process in which individual practitioners identify their own learning needs, makes plan to meet those objectives, executes those plans and finally evaluates the effectiveness of the plan in relation to their practices.

CE is as a structured process of education designed or intended to support the continuous development of pharmacists to maintain and enhance their professional competence.

The major advantage of CPD over CE is that for CPD, learning can be linked to the workplace as it is intended to be more experiential and informal.

Market Value of Reproductive Medicine & Women Healthcare in America

women's health care is forecast to grow by 6% by 2020. Most (81%) ob-gyn related services will be for women of reproductive age (18–44 years old). Growth in demand is forecast to be highest in states with the greatest population growth (Texas, Florida), where supply is currently less than adequate (western United States), and among Hispanic women. This increase in demand by 2020 will translate into a need for physicians or nonphysician clinicians, which is clinically equivalent to 2,090 full-time ob-gyns. Using today's national norms of ob-gyn related services, a modest growth in women's health care demands is estimated by 2020 that will require a larger provider workforce.

Market Value of Reproductive Medicine & Women Healthcare in Europe

Women's health was significantly lower than men's. Health was associated with education, household economic status, employment, and marital status after controlling for age. In the pooled analysis decomposition showed that 30% of the inequality was “explained", of which almost 75% came from employment, education, marital status. The differential effects of being in paid employment increased the inequality. When countries in Africa and Europe were compared, the “explained" component (31% and 39% respectively) was largely attributed to the social determinants in the African countries and to women's longevity in the European countries. Being in paid employment had a greater positive effect on the health of males in both regions.

Market Value of Reproductive Medicine & Women Healthcare in Asia and Middle East

The average labour force participation rate of women around the globe has remained stubbornly constant over the last 25 years at just over 50% of the economically active female population. There has been some progress but still, women face a labour market that offers them lower wages and lower quality jobs than their male counterparts. These trends persist even in economies in Asia and the Pacific where the female labour force participation rate in 2014 was a high 53%—roughly the same as the DMC average, which in itself is a rate that masks significant variations across countries.